Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.

Wang J, Cheng P, Pavlyukov MS, Yu H, Zhang Z, Kim SH, Minata M, Mohyeldin A, Xie W, Chen D, Goidts V, Frett B, Hu W, Li H, Shin YJ, Lee Y, Nam DH, Kornblum HI, Wang M, Nakano I

Open source

DOI: 10.1172/jci89092
Published: 2017 Aug 1
Container: The Journal of clinical investigation
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 0/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci89092,
  title = {Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.},
  author = {Wang J and Cheng P and Pavlyukov MS and Yu H and Zhang Z and Kim SH and Minata M and Mohyeldin A and Xie W and Chen D and Goidts V and Frett B and Hu W and Li H and Shin YJ and Lee Y and Nam DH and Kornblum HI and Wang M and Nakano I},
  year = {2017},
  journal = {The Journal of clinical investigation},
  doi = {10.1172/jci89092},
  url = {https://doi.org/10.1172/jci89092}
}

RIS

TY  - JOUR
TI  - Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.
AU  - Wang J
AU  - Cheng P
AU  - Pavlyukov MS
AU  - Yu H
AU  - Zhang Z
AU  - Kim SH
AU  - Minata M
AU  - Mohyeldin A
AU  - Xie W
AU  - Chen D
AU  - Goidts V
AU  - Frett B
AU  - Hu W
AU  - Li H
AU  - Shin YJ
AU  - Lee Y
AU  - Nam DH
AU  - Kornblum HI
AU  - Wang M
AU  - Nakano I
PY  - 2017
JO  - The Journal of clinical investigation
DO  - 10.1172/jci89092
UR  - https://doi.org/10.1172/jci89092
ER  -

APA

J, W., P, C., MS, P., H, Y., Z, Z., SH, K., M, M., A, M., W, X., D, C., V, G., B, F., W, H., H, L., YJ, S., Y, L., DH, N., HI, K., M, W., & I, N. (2017). Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2.. The Journal of clinical investigation. https://doi.org/10.1172/jci89092

Source records

pubmed · retrieved 2026-09-25T04:04:00.101Z